Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Enhance Quality Surveillance System for Generics
September 24, 2007
- 24.7 Million Units of Influenza Vaccines to Be Supplied for Next Season
September 24, 2007
- GENERICS NEWS IN BRIEF
September 24, 2007
- European GL on Hypertension, Coronary Artery Disease Revised
September 24, 2007
- Mr Abe's Decision to Resign Sends Out Shockwave
September 24, 2007
- Disinfection in Boiling SDS Should Be Made Obligatory to Prevent Secondary Infection of CJD
September 24, 2007
- Korosho to Encourage Innovation While Optimizing Healthcare Expenditures: Mr Erikawa
September 24, 2007
- MEDICAL DEVICE NEWS IN BRIEF
September 24, 2007
- Benefits of Research Must Be Returned to the People: Mr Toguchi
September 24, 2007
- New Sales Strategy Going Extremely Well: Mr Kashiwagi of sanofi-aventis
September 24, 2007
- Breast Cancer Will Be One of the Major Topics in Women's Health Week: Mr Nishiyama
September 24, 2007
- AltaCare Provides Int. Sales, Business Dev. Services for Pharma, Consumer Care Products
September 24, 2007
- REGULATORY NEWS IN BRIEF
September 24, 2007
- Eli Lilly Enters GP Market with Cialis
September 24, 2007
- Boehringer Ingelheim to Initiate PIII Study for BIBW2992
September 24, 2007
- Taiyo Yakuhin's Outsourcing Study Group Focuses on Barrier Isolators
September 24, 2007
- 303 Orphan Drugs under Development in US
September 24, 2007
- Boehringer Ingelheim Ties Up with Ablynx for Nanobody Therapeutics
September 24, 2007
- Takara Bio Licenses Anticancer Immunotherapy to Korean Company
September 24, 2007
- Eisai Ties Up with Salix to Copromote COLAZAL in the US
September 17, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…